PKA-Mediated stabilization of FoxH1 negatively regulates ERα activity

Molecules and Cells

Volumn 28, Issue 1, 2009, Pages 67-71

  Yum, Jinah ^a   Jeong, Hyung Min ^b   Kim, Seulki ^a   Seo, Jin Won ^b   Han, Younho ^b   Lee, Kwang Youl ^b   Yeo, Chang Yeol ^a  

^a Ewha Womans University   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Estrogen receptor ; FoxH1; Protein kinase A; Protein stability

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FORKHEAD TRANSCRIPTION FACTOR; FORSKOLIN; PROTEIN FOXH1; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ESTROGEN RESPONSIVE ELEMENT; HALF LIFE TIME; HUMAN; HUMAN CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN STABILITY; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOHEXIMIDE; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FORKHEAD TRANSCRIPTION FACTORS; FORSKOLIN; GENE EXPRESSION REGULATION; HUMANS; ISOQUINOLINES; LUCIFERASES; PROTEIN KINASE INHIBITORS; PROTEIN STABILITY; PROTEIN SYNTHESIS INHIBITORS; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SULFONAMIDES;

EID: 69849083757     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-009-0099-7     Document Type: Article

References (28)

1. Al-Dhaheri, M.H., and Rowan, B.G. (2007). Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor α promoter interaction, and changes in receptor phosphorylation. Mol. Endocrinol. 21, 439-456.
2. Arnold, S.F., Obourn, J.D., Jaffe, H., and Notides, A.C. (1995). Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. Mol. Endocrinol. 9, 24-33.
3. Chen, X., Weisberg, E., Fridmacher, V., Watanabe, M., Naco, G., and Whitman, M. (1997). Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389, 85-89.
4. Chen, D., Pace, P.E., Coombes, R.C., and Ali, S. (1999). Phosphorylation of human estrogen receptor α by protein kinase A regulates dimerization. Mol. Cell. Biol. 19, 1002-1015.
5. Chen, G., Nomura, M., Morinaga, H., Matsubara, E., Okabe, T., Goto, K., Yanase, T., Zheng, H., Lu, J., and Nawata, H. (2005). Modulation of androgen receptor transactivation by FoxH1: A newly identified androgen receptor corepressor. J. Biol. Chem. 280, 36355-36363.
6. Cho, H., and Katzenellenbogen, B.S. (1993). Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol. Endocrinol. 7, 441-452.
7. Cui, Y., Zhang, M., Pestell, R., Curran, E.M., Welshons, W.V., and Fuqua, S.A. (2004). Phosphorylation of estrogen receptor α blocks its acetylation and regulates estrogen sensitivity. Cancer Res. 64, 9199-9208.
8. Feng, W., Webb, P., Nguyen, P., Liu, X., Li, J., Karin, M., and Kushner, P.J. (2001). Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. Mol. Endocrinol. 15, 32-45.
9. Kang, K., Lee, S.B., Jung, S.H., Cha, K.H., Park, W.D., Sohn, Y.C., and Nho, C.W. (2009). Tectoridin, a poor ligand of estrogen receptor alpha, exerts its estrogenic effects via an ERK-dependent pathway. Mol. Cells 27, 351-357.
10. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494.
11. Kofron, M., Puck, H., Standley, H., Wylie, C., Old, R., Whitman, M., and Heasman, J. (2004). New roles for FoxH1 in patterning the early embryo. Development 131, 5065-5078.
12. Lannigan, D.A. (2003). Estrogen receptor phosphorylation. Steroids 68, 1-9.
13. Lee, H., and Bai, W. (2002). Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol. Cell. Biol. 22, 5835-5845.
14. Loven, M.A., Wood, J.R., and Nardulli, A.M. (2001). Interaction of estrogen receptors α and β with estrogen response elements. Mol. Cell. Endocrinol. 181, 151-163.
15. Massagué, J., and Gomis, R.R. (2006). The logic of TGFβ signaling. FEBS Lett. 580, 2811-2820.
16. McKenna, N.J., Lanz, R.B., and O'Malley, B.W. (1999). Nuclear receptor coregulators: Cellular and molecular biology. Endocrine Rev. 20, 321-344.
17. Michalides, R., Griekspoor, A., Balkenende, A., Verwoerd, D., Janssen, L., Jalink, K., Floore, A., Velds, A., van't Veer, L., and Neefjes, J. (2004). Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer. Cancer Cell 5, 597-605.
18. Nilsson, S., Makela, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., and Gustafsson, J.A. (2001). Mechanisms of estrogen action. Physiol. Rev. 81, 1535-1565.
19. Pike, M.C., Spicer, D.V., Dahmoush, L., and Press, M.F. (1993). Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev. 15, 17-35.
20. Roessler, E., Ouspenskaia, M.V., Karkera, J.D., Velez, J.I., Kantipong, A., Lacbawan, F., Bowers, P., Belmont, J.W., Towbin, J.A., Goldmuntz, E., et al. (2008). Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly. Am. J. Hum. Genet. 83, 18-29.
21. Rogatsky, I., Trowbridge, J.M., and Garabedian, M.J. (1999). Potentiation of human estrogen receptor α transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin ACDK2 complex. J. Biol. Chem. 274, 22296-22302.
22. Schier, A.F. (2003). Nodal signaling in vertebrate development. Annu. Rev. Cell Dev. Biol. 19, 589-621.
23. Sun, M., Paciga, J.E., Feldman, R.I., Yuan, Z., Coppola, D., Lu, Y.Y., Shelley, S.A., Nicosia, S.V., and Cheng, J.Q. (2001). Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor α (ERα) via interaction between ERα and PI3K. Cancer Res. 61, 5985-5991.
24. Watanabe, M., and Whitman, M. (1999). FAST-1 is a key maternal effector of mesoderm inducers in the early Xenopus embryo. Development 126, 5621-5634.
25. Whitman, M. (2001). Nodal signaling in early vertebrate embryos: Themes and variations. Dev. Cell 1, 605-617.
26. Xu, J., and Li, Q. (2003). Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol. 17, 1681-1692.
27. Zhou, S., Zawel, L., Lengauer, C., Kinzler, K.W., and Vogelstein, B. (1998). Characterization of human FAST-1, a TGF β and activin signal transducer. Mol. Cell 2, 121-127.
28. Zwart, W., Griekspoor, A., Berno, V., Lakeman, K., Jalink, K., Mancini, M., Neefjes, J., and Michalides, R. (2007). PKA-induced resistance to tamoxifen is associated with an altered orientation of ERα towards co-activator SRC-1. EMBO J. 26, 3534-3544.